Riverhead Capital Management’s Core Laboratories CLB Stock Holding History

Riverhead Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$257K	Buy	5,506 +1,000	+22%	+$46.5K	0.01%	1024
2019 Q2	$236K	Hold	4,506	–	–	0.01%	1075
2019 Q1	$311K	Hold	4,506	–	–	0.01%	925
2018 Q4	$269K	Hold	4,506	–	–	0.01%	937
2018 Q3	$522K	Buy	4,506 +600	+15%	+$67.7K	0.02%	737
2018 Q2	$493K	Buy	3,906 +100	+3%	+$12.2K	0.02%	685
2018 Q1	$412K	Buy	3,806 +400	+12%	+$44.3K	0.02%	736
2017 Q4	$373K	Buy	3,406 +100	+3%	+$9.98K	0.02%	785
2017 Q3	$326K	Buy	+3,306	New	+$320K	0.02%	767
2013 Q3	–	Sell	-16,000	Closed	-$2.43M	–	429
2013 Q2	$2.43M	Buy	+16,000	New	+$2.27M	0.08%	245

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Riverhead Capital Management's CLB Position: Q3 2019 in Review

Riverhead Capital Management increased its Core Laboratories (CLB) stake by 22% in Q3 2019, buying an estimated $46.5K and bringing the position to 5,506 shares worth $257K. The position accounts for 0.01% of the portfolio, ranked #1024.

Riverhead Capital Management first reported a position in CLB in Q2 2013 and has held it in 10 quarters since. The position peaked at $2.43M in Q2 2013. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Riverhead Capital Management held 5,506 shares of Core Laboratories worth $257K as of Q3 2019.
Riverhead Capital Management bought 1,000 Core Laboratories shares in Q3 2019, an estimated $46.5K.
Core Laboratories made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1024 holding.
Riverhead Capital Management first reported a position in Core Laboratories in Q2 2013 and has held it in 10 quarters since.
Riverhead Capital Management's Core Laboratories position peaked at $2.43M in Q2 2013.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.